Positron Emission Tomography-Computed Tomography Imaging of Selective Lobar Delivery of Stem Cells in Ex Vivo Lung Model of Mechanical Ventilation

Introduction: The delivery of cell therapies may be an important frontier to treat different respiratory diseases in the near future. However, the cell size, delivery conditions, cell viability, and effect in the pulmonary function are critical factors. We performed a proof-of-concept experiment using ex vivo lungs and novel subglottic airway device that allows for selective lobar isolation and administration of drugs and biologics in liquid solution deep into the lung tissues, while simultaneously ventilating the rest of the lung lobes. Methods: We used radiolabeled cells and positron emission tomography-computed tomography (PET-CT) imaging to demonstrate the feasibility of high-yield cell delivery to a specifically targeted lobe. This study proposes an alternative delivery method of live cells labeled with radioactive isotope into the lung parenchyma and tracks the cell delivery using PET-CT imaging. The technique combines selective lobar isolation and lobar infusion to carry large particles distal to the trachea, subtending bronchial segments and reaching alveoli in targeted regions. Results: The solution with cells and carrier achieved a complete and homogeneous lobar distribution. An increase in tissue density was shown on the computed tomography (CT) scan, and the PET-CT imaging demonstrated retention of the activity at central, peripheral lung parenchyma, and pleural surface. The increase in CT density and metabolic activity of the isotope was restricted to the desired lobe only without leak to other lobes. Conclusion: The selective lobe delivery is targeted and imaging-guided by bronchoscopy and CT to a specific diseased lobe during mechanical ventilation. The feasibility of high-yield cell delivery demonstrated in this study will lead to the development of potential novel therapies that contribute to lung health.

[1]  A. Khanna,et al.  Selective Lobe Ventilation and a Novel Platform for Pulmonary Drug Delivery , 2021, Journal of Cardiothoracic and Vascular Anesthesia.

[2]  David W. Kaczka Oscillatory ventilation redux: alternative perspectives on ventilator-induced lung injury in the acute respiratory distress syndrome , 2021, Current Opinion in Physiology.

[3]  P. W. Czoty,et al.  Effect of ethanol and cocaine on [11C]MPC-6827 uptake in SH-SY5Y cells , 2021, Molecular Biology Reports.

[4]  N. Maffulli,et al.  In Vitro Innovation of Tendon Tissue Engineering Strategies , 2020, International journal of molecular sciences.

[5]  M. Lythgoe,et al.  Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with 89Zr-oxine PET-CT , 2020, Stem Cell Research & Therapy.

[6]  R. Ruemmler,et al.  Bronchoalveolar Lavage and Oleic Acid-Injection in Pigs as a Double-Hit Model for Acute Respiratory Distress Syndrome (ARDS). , 2020, Journal of visualized experiments : JoVE.

[7]  R. Aly,et al.  Current state of stem cell-based therapies: an overview. , 2020, Stem cell investigation.

[8]  M. Bertolini,et al.  CT protocol optimisation in PET/CT: a systematic review , 2020, EJNMMI Physics.

[9]  J. Pourchez,et al.  Aerosol delivery during invasive mechanical ventilation: development of a preclinical ex vivo respiratory model for aerosol regional deposition , 2019, Scientific Reports.

[10]  A. Atala,et al.  Stromal cells from perinatal and adult sources modulate the inflammatory immune response in vitro by decreasing Th1 cell proliferation and cytokine secretion , 2019, Stem cells translational medicine.

[11]  G. Greisen,et al.  European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update , 2019, Neonatology.

[12]  Xiao-qing Chen,et al.  The role of miR-431-5p in regulating pulmonary surfactant expression in vitro , 2019, Cellular & Molecular Biology Letters.

[13]  S. Meng,et al.  Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials , 2019, BMC Pulmonary Medicine.

[14]  D. Hess,et al.  Aerosol Delivery Devices for Obstructive Lung Diseases , 2018, Respiratory Care.

[15]  David W. Kaczka,et al.  Targeted Versus Continuous Delivery of Volatile Anesthetics During Cholinergic Bronchoconstriction , 2018, Journal of engineering and science in medical diagnostics and therapy.

[16]  H. Suhonen,et al.  Quantitative Imaging of Regional Aerosol Deposition, Lung Ventilation and Morphology by Synchrotron Radiation CT , 2018, Scientific Reports.

[17]  R. Balkissoon Stem Cell Therapy for COPD: Where are we? , 2018, Chronic obstructive pulmonary diseases.

[18]  Tonglei Li,et al.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities , 2017, Acta Pharmacologica Sinica.

[19]  VerbanckSylvia,et al.  Inhaled aerosol distribution in human airways: a scintigraphy-guided study in a 3D printed model , 2016 .

[20]  Gregg A. Duncan,et al.  The Mucus Barrier to Inhaled Gene Therapy. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[22]  David W. Kaczka,et al.  Volatile Anesthetics and the Treatment of Severe Bronchospasm: A Concept of Targeted Delivery. , 2015, Drug discovery today. Disease models.

[23]  E. Fattal,et al.  Pulmonary drug delivery systems for tuberculosis treatment. , 2015, International journal of pharmaceutics.

[24]  K. Reuhl,et al.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[25]  Tilo Winkler,et al.  Lung physiology and aerosol deposition imaged with positron emission tomography. , 2013, Journal of aerosol medicine and pulmonary drug delivery.

[26]  Arzu Ari,et al.  Inhalation therapy in patients receiving mechanical ventilation: an update. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[27]  Philippe Micheau,et al.  A Prototype of Volume-Controlled Tidal Liquid Ventilator Using Independent Piston Pumps , 2006, ASAIO journal.

[28]  P. Jones,et al.  Corticosteroids for pulmonary sarcoidosis. , 2005, The Cochrane database of systematic reviews.

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  S. Kohno,et al.  Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy. , 1993, Chest.

[31]  S. Newman,et al.  Aerosol deposition considerations in inhalation therapy. , 1985, Chest.

[32]  Ewald R. Weibel,et al.  Geometry and Dimensions of Airways of Conductive and Transitory Zones , 1963 .